- Madeed raises USD 400K pre-seed led by Vision Ventures to build a preventative health platform focused on lifespan extension.
- Platform leverages lab testing to detect early warning signs of hundreds of diseases, prioritizing disease prevention and long-term health optimization.
- The funding will aid product launch and expand clinical partnerships, aiming to onboard initial members with a primary focus on the Saudi market.
Madeed
Saudi-based Madeed raised USD 400 thousand in a pre-seed round. The round was led by Vision Ventures (VV), with participation from investors including Mashhoor Aldubayan, Mazen Aldarrab, and Abdulla Nadeem Elyas.
Founded by Adam Bataineh, Madeed is a preventative health platform. It is developing a platform with a focus on extending lifespan. It aims to do so by focusing on improving the quality of life through disease prevention and long-term health optimization. Additionally, it depends on lab testing to detect early warning signs of hundreds of diseases before the appearance of symptoms.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.
